Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print August 27, 2009, doi: 10.1161/CIRCRESAHA.109.205120
A more recent version of this article appeared on September 25, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/7/639    most recent
CIRCRESAHA.109.205120v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Spiekerkoetter, E.
Right arrow Articles by Rabinovitch, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spiekerkoetter, E.
Right arrow Articles by Rabinovitch, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Pulmonary biology and circulation
Right arrow Smooth muscle proliferation and differentiation
Right arrow Pulmonary circulation and disease

Submitted on May 22, 2008
Revised on August 17, 2009
Accepted on August 19, 2009

S100A4 and Bone Morphogenetic Protein-2 Codependently Induce Vascular Smooth Muscle Cell Migration via Phospho–Extracellular Signal-Regulated Kinase and Chloride Intracellular Channel 4

Edda Spiekerkoetter ; Christophe Guignabert ; Vinicio de Jesus Perez ; Tero-Pekka Alastalo ; Janine M. Powers ; Lingli Wang ; Allan Lawrie ; Noona Ambartsumian ; Ann-Marie Schmidt ; Mark Berryman ; Richard H. Ashley ; and Marlene Rabinovitch *

From the Department of Pediatrics (E.S., C.G., V.d.J.P., T.-P.A., J.M.P., L.W., M.R.), Stanford University School of Medicine, Calif; School of Medicine and Biomedical Sciences (A.L.), University Sheffield, United Kingdom; Danish Cancer Society (N.A.), Copenhagen, Denmark; Department of Physiology (A.-M.S.), Medicine and Surgery, Columbia University, New York; Department of Biomedical Sciences (M.B.), Ohio University College of Osteopathic Medicine, Athens; and Centre for Integrative Physiology (R.H.A.), University of Edinburgh Medical School, United Kingdom.

* To whom correspondence should be addressed. E-mail: marlener{at}stanford.edu.

Rationale: S100A4/Mts1 is implicated in motility of human pulmonary artery smooth muscle cells (hPASMCs), through an interaction with the RAGE (receptor for advanced glycation end products).

Objective: We hypothesized that S100A4/Mts1-mediated hPASMC motility might be enhanced by loss of function of bone morphogenetic protein (BMP) receptor (BMPR)II, observed in pulmonary arterial hypertension.

Methods and Results: Both S100A4/Mts1 (500 ng/mL) and BMP-2 (10 ng/mL) induce migration of hPASMCs in a novel codependent manner, in that the response to either ligand is lost with anti-RAGE or BMPRII short interference (si)RNA. Phosphorylation of extracellular signal-regulated kinase is induced by both ligands and is required for motility by inducing matrix metalloproteinase 2 activity, but phospho–extracellular signal-regulated kinase 1/2 is blocked by anti-RAGE and not by BMPRII short interference RNA. In contrast, BMPRII short interference RNA, but not anti-RAGE, reduces expression of intracellular chloride channel (CLIC)4, a scaffolding molecule necessary for motility in response to S100A4/Mts1 or BMP-2. Reduced CLIC4 expression does not interfere with S100A4/Mts1 internalization or its interaction with myosin heavy chain IIA, but does alter alignment of myosin heavy chain IIA and actin filaments creating the appearance of vacuoles. This abnormality is associated with reduced peripheral distribution and/or delayed activation of RhoA and Rac1, small GTPases required for retraction and extension of lamellipodia in motile cells.

Conclusions: Our studies demonstrate how a single ligand (BMP-2 or S100A4/Mts1) can recruit multiple cell surface receptors to relay signals that coordinate events culminating in a functional response, ie, cell motility. We speculate that this carefully controlled process limits signals from multiple ligands, but could be subverted in disease.


Key words: bone morphogenetic protein • S100 protein • vascular smooth muscle cells • intracellular chloride channel • migration